Member Info for LordSnooty

Conference call to be convened at earliest convenience after Scheme documents sent out, to provide clarity to the Offer http://www.lse.co.uk/share-regulatory-news.asp?shareprice=XEN&ArticleCode=8bwy5je1&ArticleHeadline=Shareholder_Update

I hear TD Waterhouse and Schwab both do.

You will receive new GSL shares at the rate of 175 XEN shares equals 56 GSL shares. So if you have 20000 XEN shares now, you will receive 6400 new GSL shares. Any XEN shares not divisible by 175 will be pooled and sold. You will receive a cheque for your proportion of the proceeds.

formality, I'd say. They wouldn't be spending shedloads on legal fees if they weren't sure of their ground.

alert. First one this year.

126k buy at 5.50 just gone through

on today's cake would be if we get another golfing joke from Leeson.

e-bike for Snooty.

I was referring to the fact that the MMs dropped the SP successively this morning on very little volume to far below the offer price. They do this regularly in such situations, and always manage to catch a few hapless punters.

having their pound of flesh from the gullible.

Thanks for bringing some clarity to these figures, all very confusing for an old Peer struggling to comprehend how many Jéroboams of vintage Calvados remain in the cellars.

I agree with Dutch. You should understand that yesterday's RNS and the 5.95p figure mentioned in it in no way ascribes a true value of 24m pounds to XEN. As others have said, GLS has no value (and even had negative value until recently), and as such is just the empty shell into which we are reversing in order to gain access to the US and the benefits that will provide. I expect the Scheme Documents imminently, and these will show us the way forward.

still selling into any rise. They don't like it up 'em.

at least it's not about golf.

of big trades - something is afoot, and it's not Snooty's gout.

the short answer is no, the malaria project was shelved, together with several others, in favour of a strategic change of direction two or three years ago towards so-called 'orphan drugs'. This is now mainly where our future lies, although there are still other well-advanced projects at clinical stage such as PSA-EPO and OncoHist that are ongoing.

and we shall be spared any more of Leeson's incomprehensible golfistic anecdotes.

What is so special about having a financial interest? Can a spectator not have an opinion about a football match without being a player? Can a critic not write about a play without being an actor? Your logic is curious to say the least.

are supposed to be seeking a debt facility of some $150m from banks, quite apart from mortgaging future sales against the balance of capital required. Don't you think it looks a tad unprofessional to keep changing the figures?

That's a new one on me: Firestone gets its sums wrong not once but twice, and by no small margin, and you portray that as possibly being good news? In that case I hesitate to ask what you consider bad news.